Voluntary Scheme for Branded Medicines Pricing and Access

Department of Health and Social Care written question – answered at on 17 March 2023.

Alert me about debates like this

Photo of Chris Green Chris Green Conservative, Bolton West

To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Secretary of State for Science, Innovation and Technology on the Association of the British Pharmaceutical Industry proposals for a new Voluntary Scheme for Branded Medicines Pricing and Growth, including the proposals for (a) an investment facility, (b) to build a data recruitment centre and (c) a fund for a Medicines Equity Partnership.

Photo of Will Quince Will Quince Minister of State (Department of Health and Social Care)

The Department carefully considers all evidence in the public domain on matters relating to the growth and competitiveness of the United Kingdom life science sector, including the recent report by the Association of the British Pharmaceutical Industry.

The Department of Health and Social Care is in close discussions with Ministers from the Department for Science, Innovation and Technology and the Department for Business and Trade about the business environment for life sciences and its impact on investment.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.